BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Lorenzo R, Sciorati C, Ramirez GA, Colombo B, Lorè NI, Capobianco A, Tresoldi C, Cirillo DM, Ciceri F, Corti A, Rovere-Querini P, Manfredi AA; Bio Angels for COVID-BioB Study Group. Chromogranin A plasma levels predict mortality in COVID-19. PLoS One 2022;17:e0267235. [PMID: 35468164 DOI: 10.1371/journal.pone.0267235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Jerkovic I, Kovacic V, Ticinovic Kurir T, Bozic J, Tandara L. Serum Catestatin Level as a Stratification Assessment Tool in Non-Critical COVID-19 Patients. Int J Environ Res Public Health 2023;20. [PMID: 36673891 DOI: 10.3390/ijerph20021136] [Reference Citation Analysis]
2 Sciorati C, De Lorenzo R, Lorè NI, Tresoldi C, Cirillo DM, Ciceri F, Corti A, Manfredi AA, Rovere-Querini P. The elusive role of proton pump inhibitors in COVID-19: Can plasma Chromogranin A levels hold the key? Pharmacol Res 2023;187:106601. [PMID: 36513209 DOI: 10.1016/j.phrs.2022.106601] [Reference Citation Analysis]
3 Schneider F, Le Borgne P, Herbrecht JE, Danion F, Solis M, Hellé S, Betscha C, Clere-Jehl R, Lefebvre F, Castelain V, Goumon Y, Metz-Boutigue MH. Assessment of plasma Catestatin in COVID-19 reveals a hitherto unknown inflammatory activity with impact on morbidity-mortality. Front Immunol 2022;13:985472. [PMID: 36248786 DOI: 10.3389/fimmu.2022.985472] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]